CLINICAL_TRIALS
trial_result
· 2022-12-09
Clinical Trial Update: A Treatment for Severe Inflammatory Acne Subjects [Phase 4]
Summary
Phase 4 trial update for a treatment targeting acne vulgaris completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2022-12-09